{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:59:56Z","timestamp":1790625596979,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 agentura \u010cesk\u00e9 republiky","doi-asserted-by":"publisher","award":["19-05318S"],"award-info":[{"award-number":["19-05318S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["RVO:61388963"],"award-info":[{"award-number":["RVO:61388963"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["67985823"],"award-info":[{"award-number":["67985823"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114699","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T10:47:00Z","timestamp":1627296420000},"page":"114699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Neuroactive steroids, WIN-compounds and cholesterol share a common binding site on muscarinic acetylcholine receptors"],"prefix":"10.1016","volume":"192","author":[{"given":"Eva","family":"Dolej\u0161\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Chetverikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Sz\u00e1nti-Pint\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Nelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Rand\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Dole\u017eal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam E.","family":"El-Fakahany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kudov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Jakub\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114699_b0005","doi-asserted-by":"crossref","unstructured":"R.M. Eglen, Overview of muscarinic receptor subtypes, in: A.D. Fryer, Arthur Christopoulos, N.M. Nathanson (Eds.), Handb Exp Pharmacol, Springer, 2012: pp. 3\u201328. http:\/\/view.ncbi.nlm.nih.gov\/pubmed\/22222692.","DOI":"10.1007\/978-3-642-23274-9_1"},{"key":"10.1016\/j.bcp.2021.114699_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuropharm.2017.09.011","article-title":"Physiological roles of CNS muscarinic receptors gained from knockout mice","volume":"136","author":"Thomsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2021.114699_b0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01247-2017","article-title":"The mode of action of anticholinergics in asthma","volume":"52","author":"Gosens","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bcp.2021.114699_b0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10753","article-title":"Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist","volume":"482","author":"Haga","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114699_b0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature10867","article-title":"Structure and dynamics of the M3 muscarinic acetylcholine receptor","volume":"482","author":"Kruse","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114699_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature17188","article-title":"Crystal structures of the M1 and M4 muscarinic acetylcholine receptors","volume":"531","author":"Thal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114699_b0035","doi-asserted-by":"crossref","first-page":"26001","DOI":"10.1073\/pnas.1914446116","article-title":"Crystal structure of the M5 muscarinic acetylcholine receptor","volume":"116","author":"Vuckovic","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2021.114699_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/biom10020325","article-title":"Current advances in allosteric modulation of muscarinic receptors","volume":"10","author":"Jakubik","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2021.114699_b0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1476-5381.1976.tb07708.x","article-title":"The inhibitory effect of gallamine on muscarinic receptors","volume":"58","author":"Clark","year":"1976","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1474-8673.1982.tb00518.x","article-title":"A comparison of the muscarinic antagonist actions of pancuronium and alcuronium","volume":"2","author":"Dalton","year":"1982","journal-title":"J Aut. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0055","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.3390\/ph3092838","article-title":"Allosteric modulation of muscarinic acetylcholine receptors","volume":"3","author":"Jakub\u00edk","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2021.114699_b0060","doi-asserted-by":"crossref","unstructured":"R.A. Leppik, R.C. Miller, M. Eck, J.L. Paquet, Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor, Mol. Pharmacol. 45 (1994) 983\u2013990. 624.","DOI":"10.1016\/S0026-895X(25)10214-9"},{"key":"10.1016\/j.bcp.2021.114699_b0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/mol.105.014043","article-title":"Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phtha","volume":"68","author":"Huang","year":"2005","journal-title":"Mol Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12735","article-title":"Activation and allosteric modulation of a muscarinic acetylcholine receptor","volume":"504","author":"Kruse","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114699_b0075","doi-asserted-by":"crossref","unstructured":"S. Lazareno, A. Popham, N.J. Birdsall, Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site., Mol. Pharmacol. 58 (2000) 194\u2013207. 10.1124\/mol.58.1.194.","DOI":"10.1124\/mol.58.1.194"},{"key":"10.1016\/j.bcp.2021.114699_b0080","doi-asserted-by":"crossref","unstructured":"S. Lazareno, A. Popham, N.J.M. Birdsall, Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors, Mol. Pharmacol. 62 (2002) 1492\u2013505. 10.1124\/mol.62.6.1492.","DOI":"10.1124\/mol.62.6.1492"},{"key":"10.1016\/j.bcp.2021.114699_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2018.01.027","article-title":"Role of membrane cholesterol in differential sensitivity of muscarinic receptor subtypes to persistently bound xanomeline","volume":"133","author":"Rand\u00e1kov\u00e1","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2021.114699_b0090","doi-asserted-by":"crossref","unstructured":"J. Jakub\u00edk, E.E. El-Fakahany, Allosteric modulation of GPCRs of class A by cholesterol, Int. J. Mol. Sci. 22 (2021) 1953. 10.3390\/ijms22041953.","DOI":"10.3390\/ijms22041953"},{"key":"10.1016\/j.bcp.2021.114699_b0095","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0306-4530(98)00071-7","article-title":"Neurosteroids: a novel function of the brain","volume":"23","author":"Baulieu","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bcp.2021.114699_b0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives","volume":"22","author":"Rupprecht","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bcp.2021.114699_b0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000124928","article-title":"Inhibition of hypothalamic and pituitary muscarinic receptor binding by progesterone","volume":"47","author":"Klangkalya","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2021.114699_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-4731(88)90384-6","article-title":"Structure-activity relationships of steroid hormones on muscarinic receptor binding","volume":"29","author":"Klangkalya","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.bcp.2021.114699_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00210-005-1022-1","article-title":"The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors","volume":"371","author":"Horishita","year":"2005","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1139\/y92-129","article-title":"M2 muscarinic ([3H]N-methyl scopolamine) binding in micropunches of rat ventricular myocardium: characterization and modification by progesterone","volume":"70","author":"Wilkinson","year":"1992","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0022-2828(95)90006-3","article-title":"Modulation of cardiac M2 muscarinic receptor binding by progesterone-related steroids","volume":"27","author":"Wilkinson","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2021.114699_b0130","doi-asserted-by":"crossref","unstructured":"E. Dolej\u0161\u00ed, E. Sz\u00e1nti-Pint\u00e9r, N. Chetverikov, D. Nelic, A. Rand\u00e1kov\u00e1, V. Dole\u017eal, E. Kudov\u00e1, J. Jakub\u00edk, Steroids as the novel class of high-affinity allosteric modulators of muscarinic, Prepr. Available Res. Sq. (2021). 10.21203\/RS.3.RS-140412\/V1.","DOI":"10.21203\/rs.3.rs-140412\/v1"},{"key":"10.1016\/j.bcp.2021.114699_b0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jnc.14718","article-title":"Synthetic testosterone derivatives modulate rat P2X2 and P2X4 receptor channel gating","volume":"150","author":"Sivcev","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2021.114699_b0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.steroids.2016.08.010","article-title":"Physicochemical and biological properties of novel amide-based steroidal inhibitors of NMDA receptors","volume":"117","author":"Adla","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.bcp.2021.114699_b0145","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1021\/acs.jmedchem.8b00255","article-title":"Positive modulators of the N-Methyl-d-aspartate receptor: structure-activity relationship study of steroidal 3-hemiesters","volume":"61","author":"Krausova","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114699_b0150","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1021\/jm300262w","article-title":"New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation","volume":"55","author":"Varela","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114699_b0155","doi-asserted-by":"crossref","unstructured":"M.M. Budelier, W.W.L. Cheng, L. Bergdoll, Z.-W. Chen, J. Abramson, K. Krishnan, M. Qian, D.F. Covey, J.W. Janetka, A.S. Evers, Click chemistry reagent for identification of sites of covalent ligand incorporation in integral membrane proteins, Anal. Chem. 89 (2017) 2636\u20132644. 10.1021\/acs.analchem.6b05003.","DOI":"10.1021\/acs.analchem.6b05003"},{"key":"10.1016\/j.bcp.2021.114699_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/cbdd.13059","article-title":"Synthesis of novel and functionally selective non- competitive muscarinic antagonists as chemical probes","volume":"91","author":"Boulos","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bcp.2021.114699_b0165","doi-asserted-by":"crossref","unstructured":"E.E. El-Fakahany, J. Jakubik, Radioligand binding at muscarinic receptors, in: J. Myslivecek, J. Jakubik (Eds.), Muscarinic Recept. From Struct. to Anim. Model., Humana Press, Springer Science + Business Media LLC, New York, 2016: pp. 37\u201368. 10.1007\/978-1-4939-2858-3_3.","DOI":"10.1007\/978-1-4939-2858-3_3"},{"key":"10.1016\/j.bcp.2021.114699_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214255","article-title":"Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators","volume":"14","author":"Jakub\u00edk","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2021.114699_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chemphyslip.2016.04.006","article-title":"Interaction of G protein coupled receptors and cholesterol","volume":"199","author":"Gimpl","year":"2016","journal-title":"Chem. Phys. Lipids."},{"key":"10.1016\/j.bcp.2021.114699_b0180","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1210\/endo.139.12.6390","article-title":"Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition\/interaction amino acid sequence and consensus pattern","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2021.114699_b0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2008.05.001","article-title":"A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor","volume":"16","author":"Hanson","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2021.114699_b0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2009.01.028","article-title":"Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways","volume":"606","author":"Michal","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0195","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s11064-014-1325-z","article-title":"Changes in membrane cholesterol differentially influence preferential and non-preferential signaling of the M1 and M3 muscarinic acetylcholine receptors","volume":"40","author":"Michal","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2021.114699_b0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1124\/mol.114.096925","article-title":"The molecular basis of oligomeric organization of the human M3 muscarinic acetylcholine receptor","volume":"87","author":"Liste","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114699_b0205","doi-asserted-by":"crossref","unstructured":"K. Mohr, C. Tr\u00e4nkle, U. Holzgrabe, Structure\/activity relationships of M2 muscarinic allosteric modulators., Receptors Channels. 9 (2003) 229\u201340. http:\/\/view.ncbi.nlm.nih.gov\/pubmed\/12893536.","DOI":"10.1080\/10606820308264"},{"key":"10.1016\/j.bcp.2021.114699_b0210","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.104.080358","article-title":"Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators","volume":"313","author":"Jakub\u00edk","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:15:29Z","timestamp":1777389329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S0006295221003129"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114699","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroactive steroids, WIN-compounds and cholesterol share a common binding site on muscarinic acetylcholine receptors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114699"}}